| 1 |
Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations |
|
| | Shweta Jakhmola, Nisha Amarnath Jonniya, Md Fulbabu Sk, Annu Rani, Parimal Kar, Hem Chandra Jha | | | ACS Chemical Neuroscience. 2021; 12(16): 3060 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Update on disease-modifying therapies for multiple sclerosis |
|
| | Diana L Vargas,William R Tyor | | | Journal of Investigative Medicine. 2017; 65(5): 883 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Signalling by protein phosphatases and drug development: A systems-centred view |
|
| | Nguyen, L.K. and Matallanas, D. and Croucher, D.R. and Von Kriegsheim, A. and Kholodenko, B.N. | | | FEBS Journal. 2013; 280(2): 751-765 | | | [Pubmed] [Google Scholar] | | | 4 |
Signalling by protein phosphatases and drug development: a systems-centred view |
|
| | Lan K. Nguyen,David Matallanas,David R. Croucher,Alexander von Kriegsheim,Boris N. Kholodenko | | | FEBS Journal. 2013; 280(2): 751 | | | [Pubmed] [Google Scholar] [DOI] | |
|
